Article ; Online: Impact of COVID-19 on initiation of biologic therapy prescriptions for chronic inflammatory diseases.
2021 Volume 89, Issue 1, Page(s) 105253
| MeSH term(s) | Biological Products/therapeutic use ; Biological Therapy ; COVID-19 ; Humans ; Prescriptions ; SARS-CoV-2 | |||||
|---|---|---|---|---|---|---|
| Chemical Substances | Biological Products | |||||
| Language | English | |||||
| Publishing date | 2021-07-24 | |||||
| Publishing country | France | |||||
| Document type | Letter | |||||
| ZDB-ID | 2020487-5 | |||||
| ISSN | 1778-7254 ; 1297-319X | |||||
| ISSN (online) | 1778-7254 | |||||
| ISSN | 1297-319X | |||||
| DOI | 10.1016/j.jbspin.2021.105253 | |||||
| Shelf mark |
|
|||||
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
| Zs.A 4590: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.